Pediapharm Inc. (CVE:PDP – Get Free Report) rose 1.7% during trading on Wednesday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12. The stock has a market cap of C$66.36 million and a P/E ratio of -4.11. The firm’s 50 day moving average is C$0.30 and its 200 day moving average is C$0.30.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Featured Stories
- Five stocks we like better than Pediapharm
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- United Airlines Soars on Earnings Beat
- What is a Special Dividend?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Roth IRA Calculator: Calculate Your Potential Returns
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
